Bioequivalence, AUC, Cmax, Pharmacokinetics Clinical Trial
Official title:
A Two-way Crossover, Open-label, Single-dose, Fasting, Bioequivalence Study of Memantinol® (JSC "GEROPHARM", Russia) 20 mg Tablets Versus Akatinol Memantine® (Merz Pharma GmbH & Co. KGaA, Germany) 20 mg Tablets in Normal Healthy Subjects
This study are two-way crossover, open-label, single-dose, fasting, bioequivalence study of Memantinol® (JSC "GEROPHARM", Russia) 20 mg tablets versus Akatinol Memantine® (Merz Pharma GmbH & Co. KGaA, Germany) 20 mg tablets in normal healthy subjects
Study to evaluate the bioequivalence of orally administered memantinol preparations, film-coated tablets, 20 mg ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02185534 -
Clopidogrel Bioequivalence Study in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01921920 -
Prilosec Bioequivalence Study in Healthy Volunteers
|
Phase 1 |